Biopharma and med-tech companies raising money in public or private financings, including: 4DMedical, Alamar, Anaptysbio,Arch, Artelo, Centivax, First Tracks, Kailera, Oncomatryx.
Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Deciphera, Eisai, GC, GSK, Immunitybio, Mars Bioimaging, Nuvation, Ono, OS Therapies, Pharming, Regeneron, Sanofi, Tarsus, Viatris.
Clinical updates for biopharma and med tech in Asia-Pacific, including data readouts and publications: Brightgene, Dizal, Harbour, Immunexpress, Innovent, Novo Nordisk, Otsuka, Prestige, Radiopharm, United Laboratories.
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: ARS, Bavarian Nordic, Crinetics, Eisai, GSK, Johnson & Johnson, Medtronic, Novo Nordisk, Nuvation Bio, OS Therapies, Pharming, Rocket, Sanofi, Siga.
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Anaptysbio, Innate, Long Bridge Medical, Sensus, Skincure Oncology, Teleflex.